Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
Go back to Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial| Aethlon Medical, Inc. (NASDAQ: AEMD) | Delayed: 2.06 -0.43 (17.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.49 | 52 Week High | $9.09 | |||
| Open | $2.29 | 52 Week Low | $4.02 | |||
| Day High | $2.32 | P/E | N/A | |||
| Day Low | $1.92 | EPS | $-0.05 | |||
| Volume | 846,868 | |||||
